Total Payments
$3,092
2024 Payments
$433.94
Companies
25
Transactions
179
Medicare Patients
16,036
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$2,950 (95.4%)
Education$142.40 (4.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,950 | 176 | 95.4% |
| Education | $142.40 | 3 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $920.73 | 64 | $0 (2023) |
| ABBVIE INC. | $654.94 | 40 | $0 (2024) |
| Janssen Biotech, Inc. | $208.96 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $199.34 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $171.60 | 12 | $0 (2024) |
| Lilly USA, LLC | $144.88 | 7 | $0 (2021) |
| Allergan, Inc. | $113.12 | 1 | $0 (2020) |
| GENZYME CORPORATION | $104.87 | 5 | $0 (2024) |
| Galderma Laboratories, L.P. | $66.00 | 5 | $0 (2023) |
| Amgen Inc. | $56.56 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $433.94 | 19 | ABBVIE INC. ($136.43) |
| 2023 | $292.38 | 16 | AbbVie Inc. ($69.99) |
| 2022 | $505.12 | 23 | ABBVIE INC. ($248.75) |
| 2021 | $501.33 | 38 | AbbVie Inc. ($145.38) |
| 2020 | $374.20 | 19 | PFIZER INC. ($139.90) |
| 2019 | $360.30 | 24 | PFIZER INC. ($272.38) |
| 2018 | $406.66 | 27 | PFIZER INC. ($205.19) |
| 2017 | $218.14 | 13 | PFIZER INC. ($122.61) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $66.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: Immunology | ||||||
| 09/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.82 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Other Advanced Wound Management | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Inflammation | ||||||
| 05/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 04/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: IMMUNOLOGY | ||||||
| 03/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 03/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/29/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Inflammation | ||||||
| 11/16/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Immunology | ||||||
| 09/28/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 4,072 | 8,260 | $1.4M | $270,409 |
| 2022 | 19 | 4,021 | 8,131 | $1.4M | $261,056 |
| 2021 | 24 | 3,916 | 7,489 | $1.4M | $278,867 |
| 2020 | 23 | 4,027 | 7,581 | $925,708 | $243,011 |
Total Patients
16,036
Total Services
31,461
Medicare Billing
$1.1M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,231 | 1,802 | $535,194 | $101,628 | 19.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 927 | 1,335 | $297,705 | $50,895 | 17.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 329 | 363 | $122,694 | $23,503 | 19.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 203 | 235 | $88,830 | $18,217 | 20.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 664 | 3,742 | $86,066 | $17,736 | 20.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 206 | 206 | $76,014 | $13,849 | 18.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 43 | 58 | $32,596 | $6,809 | 20.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 45 | 51 | $30,294 | $6,186 | 20.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 11 | 19 | $24,225 | $5,754 | 23.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 136 | 145 | $26,970 | $5,096 | 18.9% |
| 69100 | Biopsy of ear | Office | 2023 | 51 | 53 | $17,013 | $2,941 | 17.3% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 40 | 49 | $16,562 | $2,860 | 17.3% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $11,913 | $2,709 | 22.7% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 34 | 35 | $14,245 | $2,702 | 19.0% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 11 | 18 | $8,388 | $1,739 | 20.7% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 20 | $9,160 | $1,368 | 14.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 35 | $5,880 | $1,313 | 22.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 24 | 24 | $5,712 | $1,265 | 22.1% |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 13 | 14 | $4,928 | $994.32 | 20.2% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 12 | 12 | $4,920 | $983.74 | 20.0% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 11 | $4,587 | $938.86 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $5,880 | $923.10 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,244 | 1,760 | $519,200 | $99,454 | 19.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 922 | 1,318 | $291,278 | $50,894 | 17.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 335 | 363 | $122,694 | $24,477 | 19.9% |
About Dr. John Biltz, MD
Dr. John Biltz, MD is a Dermatology healthcare provider based in Corsicana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225001860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Biltz, MD has received a total of $3,092 in payments from pharmaceutical and medical device companies, with $433.94 received in 2024. These payments were reported across 179 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,950).
As a Medicare-enrolled provider, Biltz has provided services to 16,036 Medicare beneficiaries, totaling 31,461 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Corsicana, TX
- Active Since 02/13/2006
- Last Updated 05/13/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1225001860
Products in Payments
- EUCRISA (Drug) $920.73
- SKYRIZI (Biological) $444.17
- DUPIXENT (Biological) $260.30
- TREMFYA (Drug) $236.28
- TALTZ (Drug) $144.88
- HUMIRA (Biological) $142.87
- BOTOX COSMETIC (Biological) $113.12
- Otezla (Drug) $56.56
- Sotyktu (Drug) $50.04
- BLU-U (Medical Supply) $41.52
- COSENTYX (Biological) $41.50
- LIBTAYO (Biological) $41.47
- Cimzia (Drug) $41.23
- Humira (Biological) $40.48
- AKLIEF (Drug) $39.32
- DORYX (Drug) $34.51
- ILUMYA (Biological) $31.61
- LEVULAN KERASTICK (Drug) $29.30
- OPZELURA (Drug) $28.82
- ADBRY (Biological) $28.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.